Doctor profile · Federal record
Dr. Lawrence Finkel, M.D.
Dermatology Physician (CMS: Dermatology) · Specialist · Warrenton, VA
- NPI 1922065424
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 44 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
360 Church St
Warrenton, VA 201862735
(540) 347-2020
fax (540) 341-7980
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- November 27, 2007
- Year of graduation
- 1982 — 44 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Virginia #0101226879
- Medicaid
- VA #5902592
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1922065424. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,374
Distinct HCPCS
10
Medicare allowed
$320,564
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 5,979 | 452 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,120 | 573 | $88 | |
17000 |
Destruction of precancer skin growth, 1 growth | 848 | 514 | $59 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 420 | 43 | $1 | |
11102 |
Biopsy of related skin growth, first growth | 197 | 161 | $98 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 160 | 114 | $165 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 155 | 155 | $109 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 152 | 134 | $123 | |
96372 |
Injection of drug or substance under skin or into muscle | 61 | 34 | $14 | |
11103 |
Biopsy of related skin growth, each additional growth | 47 | 39 | $50 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 423. This provider delivers 22× the peer median.Open Payments
Industry payments received
All-time total
$652
Transactions
25
Manufacturers
11
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 7 | $249.36 | |
| ABBVIE INC. | 4 | $105.48 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $86.51 | |
| Amgen Inc. | 2 | $56.18 | |
| UCB, Inc. | 1 | $41.63 | |
| PFIZER INC. | 2 | $32.25 | |
| Verrica Pharmaceuticals Inc. | 1 | $18.27 | |
| Lilly USA, LLC | 1 | $18.07 | |
| Arcutis Biotherapeutics, Inc. | 1 | $16.04 | |
| Incyte Corporation | 1 | $14.51 | |
| Solta Medical, a division of Bausch Health US, LLC | 1 | $13.80 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
397
Patients
212
Total drug cost
$308,234
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Clobetasol Propionate | Generic | 66 | 37 | $4,634 |
| Triamcinolone Acetonide | Generic | 61 | 37 | $693 |
| Doxycycline Hyclate | Generic | 41 | 11 | $906 |
| Ketoconazole | Generic | 35 | 22 | $1,169 |
| Mometasone Furoate | Generic | 32 | 23 | $970 |
| Hydrocortisone | Generic | 30 | 21 | $240 |
| Imiquimod | Generic | 28 | 18 | $701 |
| Doxycycline Monohydrate | Generic | 20 | 17 | $676 |
| Mupirocin | Generic | 18 | 15 | $160 |
| Clindamycin Phosphate | Generic | 14 | 0 | $575 |
Frequently asked questions
What is Dr. Lawrence Finkel's medical specialty?
Dr. Lawrence Finkel practices Dermatology Physician in Warrenton, VA.
Where does Dr. Lawrence Finkel practice?
Dr. Lawrence Finkel practices at 360 Church St, Warrenton, VA 201862735. Office phone: 5403472020.
What is Dr. Lawrence Finkel's NPI?
Dr. Lawrence Finkel's National Provider Identifier (NPI) is 1922065424, issued by NPPES.
Does Dr. Lawrence Finkel accept Medicare assignment?
Yes. Dr. Lawrence Finkel accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lawrence Finkel commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.